Results 41 to 50 of about 9,185 (249)

A novel remnant liver-first strategy for liver autotransplantation in patients with end-stage hepatic alveolar echinococcosis: a retrospective case series. [PDF]

open access: yesInt J Surg, 2023
Background: Ex vivo liver resection combined with autotransplantation is an effective therapeutic strategy for unresectable end-stage hepatic alveolar echinococcosis (HAE).
Lv T   +13 more
europepmc   +2 more sources

A CT-based radiomics model for predicting lymph node metastasis in hepatic alveolar echinococcosis patients to support lymph node dissection. [PDF]

open access: yesEur J Med Res
Background Hepatic alveolar echinococcosis (AE) is a severe zoonotic parasitic disease, and accurate preoperative prediction of lymph node (LN) metastasis in AE patients is crucial for disease management, but it remains an unresolved challenge.
Zhou Y   +5 more
europepmc   +2 more sources

Fifty-five cases of hepatic alveolar echinococcosis combined with lymph node metastasis: A retrospective study. [PDF]

open access: yesWorld J Gastroenterol
BACKGROUND Lymph node metastasis is a specific type of metastasis in hepatic alveolar echinococcosis (AE). Currently, there is a scarcity of describing the clinical characteristics and lymph node metastasis rules of patients with hepatic AE combined with
Aimaitijiang Y   +3 more
europepmc   +2 more sources

Efficacy of percutaneous microwave ablation guided by contrast-enhanced and two-dimensional ultrasound for in hepatic alveolar echinococcosis in difficult/dangerous locations. [PDF]

open access: yesFront Med (Lausanne)
Background Ultrasound-guided microwave ablation (MWA) has become a popular method for treating malignant liver tumors. However, few studies have investigated its use in the treatment of hepatoalveolar echinococcosis (HAE). This study aimed to explore the
Huang W   +6 more
europepmc   +2 more sources

Successful Interventional Therapy for Portal Vein Stenosis after Ex Vivo Liver Resection and Autotransplantation in End-Stage Hepatic Alveolar Echinococcosis with Cavernous Transformation. [PDF]

open access: yesAnn Transplant
Background End-stage hepatic alveolar echinococcosis (AE) can result in cavernous transformation of the portal vein (CTPV) due to extensive invasion of the portal vein.
Yilihaer Y   +5 more
europepmc   +2 more sources

Mixed infection with two types of echinococcosis misdiagnosed as hepatic alveolar echinococcosis [PDF]

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2019
Qiancheng Du, Chenliang Hu, Yanfei Li
doaj   +3 more sources

Metabolic mechanism and pharmacological study of albendazole in secondary hepatic alveolar echinococcosis (HAE) model rats. [PDF]

open access: yesAntimicrob Agents Chemother
Albendazole (ABZ) is the primary treatment for alveolar echinococcosis (AE); however, its limited solubility impacts oral bioavailability, affecting therapeutic outcomes. In this study, various ABZ-solubilizing formulations, including albendazole crystal
Li C   +5 more
europepmc   +2 more sources

Applying LASSO logistic regression for the prediction of biliary complications after ex vivo liver resection and autotransplantation in patients with end-stage hepatic alveolar echinococcosis. [PDF]

open access: yesEur J Med Res
Background The purpose of this study was to explore the relevant risk factors associated with biliary complications (BCs) in patients with end-stage hepatic alveolar echinococcosis (HAE) following ex vivo liver resection and autotransplantation (ELRA ...
Lin X, Shao YM, Zhang RQ, Aji T.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy